Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma

Xi'an No.3 Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
relapsed/refractory multiple myeloma(mm), allogeneic car-t, umbilical cord blood-derived, relapsed/refractory multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 826356
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.